Purification of ACVR1 for co-crystallisation with LDN-193189 and other compounds
| Main Authors: | Roslin Adamson, Mizio Matteucci, Paul E. Brennan, Alex N. Bullock |
|---|---|
| Format: | info dataset eJournal |
| Terbitan: |
, 2018
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/1173004 |
Daftar Isi:
- Purification of constitutively active ACVR1 for co-crystallisation with LDN-193189 and three other compounds.
- The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].